Control of muscle glucose uptake: Test of the rate-limiting step paradigm in conscious, unrestrained mice

Journal of Physiology

Volumn 562, Issue 3, 2005, Pages 925-935

  Fueger, Patrick T ^a,b   Shearer, Jane ^a   Bracy, Deanna P ^a   Posey, Kelly A ^a   Pencek, R Richard ^a   McGuiness, Owen P ^a   Wasserman, David H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 4; HEXOKINASE; INSULIN; SODIUM CHLORIDE; GLUCOSE 6 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; CLEARANCE; CONSCIOUSNESS; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE OVEREXPRESSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HYPERINSULINEMIA; IMMOBILIZATION STRESS; JUGULAR VEIN; MALE; MUSCLE METABOLISM; MUSCLE RESECTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE; TISSUE SPECIFICITY; VASTUS LATERALIS MUSCLE; VEIN CATHETERIZATION; WILD TYPE; GENE; GLUCOSE METABOLISM; GLUT4 GENE; HEXOKINASE II GENE; INSULIN BLOOD LEVEL; INSULIN INFUSION; MOUSE; MUSCLE; MUSCLE GLUCOSE UPTAKE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD GLUCOSE; CONSCIOUSNESS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEXOKINASE; HUMANS; HYPERINSULINISM; INSULIN; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL;

EID: 13844266843     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.076158     Document Type: Article

References (49)

1. Bao S & Garvey WT (1997). Exercise in transgenic mice overexpressing GLUT4 glucose transporters: effects on substrate metabolism and glycogen regulation. Metabolism 46, 1349-1357.
2. Baron AD (1994). Hemodynamic actions of insulin. Am J Physiol 267, E187-E202.
3. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A & Brechtel G (1995). Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96, 786-792.
4. Benthem L & Taborsky GJ Jr (1998). Hyperglycemia suppresses the sympatho-adrenal response to hypoxia, but not to handling stress. J Auton Nerv Syst 73, 149-155.
5. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C & DeFronzo RA (1996). Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45, 915-925.
6. Bonadonna RC, Saccomani MP, Seely L, Zych KS, Ferrannini E, Cobelli C & DeFronzo RA (1993). Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes 42, 191-198.
7. Chan TM & Exton JH (1976). A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71, 96-105.
8. Chang PY, Jensen J, Printz RL, Granner DK, Ivy JL & Moller DE (1996). Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake. J Biol Chem 271, 14834-14839.
9. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH & Rattigan S (2003). Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 284, E241-E258.
10. Deems RO, Evans JL, Deacon RW, Honer CM, Chu DT, Burki K, Fillers WS, Cohen DK & Young DA (1994). Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37, 1097-1104.
11. Delp MD & Duan C (1996). Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80, 261-270.
12. Fell DA & Thomas S (1995). Physiological control of metabolic flux: the requirement for multisite modulation. Biochem J 311 35-39.
13. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK & Wasserman DH (2004a). Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice. Diabetes 53, 306-314.
14. Fueger PT, Bracy DP, Malabanan CM, Pencek RR & Wasserman DH (2004b). Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286, E77-E84.
15. Fueger PT, Heikkinen S, Bracy DP, Malabanan CM, Pencek RR, Laakso M & Wasserman DH (2003). Hexokinase II partial knockout impairs exercise-stimulated glucose uptake in oxidative muscles of mice. Am J Physiol Endocrinol Metab 285, E958-E963.
16. Furler SM, Jenkins AB, Storlien LH & Kraegen EW (1991). In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. Am J Physiol 261, E337-E347.
17. Gulve EA, Ren JM, Marshall BA, Gao J, Hansen PA, Holloszy JO & Mueckler M (1994). Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. J Biol Chem 269, 18366-18370.
18. Halseth AE, Bracy DP & Wasserman DH (1998). Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake. J Appl Physiol 85, 2305-2313.
19. Halseth AE, Bracy DP & Wasserman DH (1999). Overexpression of hexokinase II increases insulin- and exercise-stimulated muscle glucose uptake in vivo. Am J Physiol 276, E70-E77.
20. Han XX & Bonen A (1998). Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274, E700-E707.
21. Hansen PA, Gulve EA, Marshall BA, Gao J, Pessin JE, Holloszy JO & Mueckler M (1995). Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J Biol Chem 270, 1679-1684.
22. Hansen PA, Marshall BA, Chen M, Holloszy JO & Mueckler M (2000). Transgenic overexpression of hexokinase II in skeletal muscle does not increase glucose disposal in wild-type or Glut1-overexpressing mice. J Biol Chem 275, 22381-22386.
23. Ikemoto S, Thompson KS, Itakura H, Lane MD & Ezaki O (1995 a). Expression of an insulin-responsive glucose transporter (GLUT4) minigene in transgenic mice: effect of exercise and role in glucose homeostasis. Proc Natl Acad Sci U S A 92, 865-869.
24. Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD & Ezaki O (1995b). High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci U S A 92, 3096-3099.
25. Kelley DE, Williams KV & Price JC (1999). Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. Am J Physiol 277, E361-E369.
26. Koistinen HA & Zierath JR (2002). Regulation of glucose transport in human skeletal muscle. Ann Med 34, 410-418.
27. Kraegen EW, James DE, Jenkins AB & Chisholm DJ (1985). Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248, E353-E362.
28. Liu ML, Gibbs EM, McCoid SC, Milici AJ, Stukenbrok HA, McPherson RK, Treadway JL & Pessin JE (1993). Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. Proc Natl Acad Sci U S A 90 11346-11350.
29. Lloyd B, Burrin J, Smythe P & Alberti KG (1978). Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24, 1724-1729.
30. Lombardi AM, Moller D, Loizeau M, Girard J & Leturque A (1997). Phenotype of transgenic mice overexpressing GLUT4 and hexokinase II in muscle. FASEB J 11, 1137-1144.
31. Marshall BA, Hansen PA, Ensor NJ, Ogden MA & Mueckler M (1999). GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance. Am J Physiol 276, E390-E400.
32. Marshall BA & Mueckler MM (1994). Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice. Am J Physiol 267, E738-E744.
33. Morgan CR & Lazarow A (1965). Immunoassay of pancreatic and plasma insulin following alloxan injection of rats. Diabetes 14 669-671.
34. Niswender KD, Shiota M, Postic C, Cherrington AD & Magnuson MA (1997). Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272, 22570-22575.
35. Olson A, Liu M, Moye-Rowley W, Buse J, Bell G & Pessin J (1993). Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice. J Biol Chem 268, 9839-9846.
36. Petersen HA, Fueger PT, Bracy DP, Wasserman DH & Halseth AE (2003). Fiber type-specific determinants of Vmax for insulin-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 284 E541-E548.
37. Petersen KF & Shulman GI (2002). Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90, 11G-18G.
38. Postic C, Leturque A, Rencurel F, Printz RL, Forest C, Granner DK & Girard J (1993). The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes 42, 922-929.
39. Printz RL, Koch S, Potter LR, O'Doherty RM, Tiesinga JJ, Moritz S & Granner DK (1993). Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. J Biol Chem 268, 5209-5219.
40. Rattigan S, Clark MG & Barrett EJ (1997). Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 46, 1381-1388.
41. Rattigan S, Wallis MG, Youd JM & Clark MG (2001). Exercise training improves insulin-mediated capillary recruitment in association with glucose uptake in rat hindlimb. Diabetes 50, 2659-2665.
42. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO & Mueckler M (1993). Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268, 16113-16115.
43. Ren JM, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM & Shulman GI (1995). Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95, 429-432.
44. Treadway JL, Hargrove DM, Nardone NA, McPherson RK, Russo JF, Milici AJ, Stukenbrok HA, Gibbs EM, Stevenson RW & Pessin JE (1994). Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem 269, 29956-29961.
45. Tsao TS, Burcelin R, Katz EB, Huang L & Charron MJ (1996). Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45, 28-36.
46. Wallberg-Henriksson H & Zierath JR (2001). GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review). Mol Membr Biol 18, 205-211.
47. Williams KV, Bertoldo A, Mattioni B, Price JC, Cobelli C & Kelley DE (2003). Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. J Clin Endocrinol Metab 88, 1271-1279.
48. Williams KV, Price JC & Kelley DE (2001). Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. Diabetes 50, 2069-2079.
49. Youn JH, Kim JK & Steil GM (1995). Assessment of extracellular glucose distribution and glucose transport activity in conscious rats. Am J Physiol 268, E712-E721.